Clinical Trials
8 trialsNCT05378763 2026-05-22
PINNACLE
Spectrum Pharmaceuticals, Inc
Phase 3 Suspended
NCT05155332 2026-05-20
A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)
Boehringer Ingelheim
Phase 1 Suspended
NCT02354547 2026-05-08
A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors
SynerGene Therapeutics, Inc.
Phase 1 Suspended
NCT06653010 2026-05-07
Wondercel-UWD1
Wondercel Biotech (ShenZhen)
Phase EARLY_PHASE1 Suspended
NCT06653023 2026-05-07
Wondercel-UWD3
Wondercel Biotech (ShenZhen)
Phase EARLY_PHASE1 Suspended
NCT06662227 2026-05-07
Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors
Wondercel Biotech (ShenZhen)
Phase EARLY_PHASE1 Suspended
NCT06663046 2026-05-07
Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma
Wondercel Biotech (ShenZhen)
Phase EARLY_PHASE1 Suspended
NCT06675513 2026-05-07
Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer
Wondercel Biotech (ShenZhen)
Phase EARLY_PHASE1 Suspended